Bourgeon Capital Management LLC Grows Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Bourgeon Capital Management LLC raised its stake in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) by 56.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,150 shares of the company’s stock after buying an additional 1,500 shares during the quarter. […]